Browsing Tag
Arthritis
16 posts
Wearing high heels and arthritis: What is the real link between fashion choices and long-term joint health?
Wearing high heels changes body posture and joint load, raising arthritis risk. Learn the science, risks, and preventive tips for long-term joint health.
How to treat gout at home using diet, heat therapy, and natural pain relief oils
Discover what causes gout, how uric acid crystals damage joints, and how you can treat gout at home using diet, heat therapy, hydration, and natural oils.
Say goodbye to gout—How to reduce uric acid naturally
Gout is a chronic form of inflammatory arthritis caused by the buildup of uric acid crystals in the…
Understanding Arthritis: A deep dive into causes, types, and home remedies
Arthritis, a term that encompasses over a hundred different conditions affecting joints and connective tissues, presents a significant…
FDA approves biosimilar SIMLANDI by Alvotech and Teva Pharmaceuticals
Alvotech and Teva Pharmaceuticals have achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval…
Takeda’s TAK-279 meets primary endpoint in Phase 2b trial for psoriatic arthritis
Takeda Pharmaceutical Company announced positive results from its Phase 2b clinical trial for TAK-279, an investigational oral TYK2…
Home remedies for Arthritis: Natural ways to manage joint inflammation
Arthritis, characterized by joint inflammation, can cause immense pain and restrict physical movements, leading to frustration for those…
Lupin launches authorized generic of PENNSAID in US to tap $509m osteoarthritis knee pain market
Lupin launches the authorized generic of PENNSAID in the U.S., targeting the $509M osteoarthritis knee pain market with a proven, cost-effective NSAID solution.
Lupin secures Health Canada approval for Enbrel biosimilar – Rymti
Lupin Limited has secured approval from Health Canada for Rymti, the company’s biosimilar to Enbrel (etanercept), an inhibitor…
Bio-Thera, Hikma Pharmaceuticals sign $150m licensing deal for BAT2206
Chinese biopharma company Bio-Thera Solutions has signed a commercialization and license deal worth up to $150 million with…